((自动化翻译由路透提供，请见免责声明 ))
11月11日 - ** Hims & Hers Health Inc 股价飙升至历史新高，上周上调年度利润预期后，股价上涨19%并延续近期涨势。
** HIMS盘中最高触及29.68美元，最新报28.00美元
** 这家远程医疗公司11月5日将其全年利润预期从13.7-14亿美元上调至14.6-14.7亿美元，并表示将在2025年将诺和诺德公司 糖尿病和减肥药 利拉鲁肽的仿制药 (link)。
** 诺和诺德和礼来 生产的减肥药需求激增，导致药物短缺，因此可以根据美国法规生产这些药物。
** HIMS目前的年度涨幅为213%，而标普500指数 的涨幅为26
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.